These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 9973007)
41. Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia. Steffensen R; Grande P; Pedersen F; Haunsø S Int J Cardiol; 1993 Jul; 40(2):143-53. PubMed ID: 8349377 [TBL] [Abstract][Full Text] [Related]
42. Effects of diltiazem, propranolol, and their combination in the control of atrial fibrillation. Dahlström CG; Edvardsson N; Nasheng C; Olsson SB Clin Cardiol; 1992 Apr; 15(4):280-4. PubMed ID: 1563131 [TBL] [Abstract][Full Text] [Related]
43. Circadian rhythms of atrioventricular conduction properties in chronic atrial fibrillation with and without heart failure. Hayano J; Sakata S; Okada A; Mukai S; Fujinami T J Am Coll Cardiol; 1998 Jan; 31(1):158-66. PubMed ID: 9426035 [TBL] [Abstract][Full Text] [Related]
44. Rate-control treatment and mortality in atrial fibrillation. Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160 [TBL] [Abstract][Full Text] [Related]
45. Mid- and long-term similarity of ventricular response to paroxysmal atrial fibrillation: digoxin versus placebo. Hnatkova K; Murgatroyd FD; Poloniecki J; Waktare JE; Alferness CA; Camm AJ; Malik M Pacing Clin Electrophysiol; 1998 Sep; 21(9):1735-40. PubMed ID: 9744436 [TBL] [Abstract][Full Text] [Related]
46. The drug treatment of atrial fibrillation. Channer KS Br J Clin Pharmacol; 1991 Sep; 32(3):267-73. PubMed ID: 1685662 [TBL] [Abstract][Full Text] [Related]
47. Distribution of fast heart rate episodes during paroxysmal atrial fibrillation. Hnatkova K; Murgatroyd FD; Alferness CA; Camm AJ; Malik M Heart; 1998 May; 79(5):497-501. PubMed ID: 9659199 [TBL] [Abstract][Full Text] [Related]
48. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation. Lewis RV; McDevitt DG Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426 [TBL] [Abstract][Full Text] [Related]
49. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy. Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366 [TBL] [Abstract][Full Text] [Related]
50. Pharmacologic management of atrial fibrillation: current therapeutic strategies. Lévy S Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354 [TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of oral amiodarone in controlling heart rate in patients with persistent atrial fibrillation who have undergone digitalisation. Kochiadakis GE; Kanoupakis EM; Igoumenidis NE; Mavrakis HE; Kafarakis PK; Vardas PE Hellenic J Cardiol; 2005; 46(5):336-40. PubMed ID: 16295942 [TBL] [Abstract][Full Text] [Related]
53. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem. Gonzalez ER; Ornato JP; Lawson CL Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281 [TBL] [Abstract][Full Text] [Related]
54. Graphical representation of complex data--diurnal patterns of initiations of atrial fibrillation episodes. Hnatkova K; Murgatroyd FD; Guo X; Camm AJ; Malik M Pacing Clin Electrophysiol; 1997 Nov; 20(11):2848-52. PubMed ID: 9392815 [TBL] [Abstract][Full Text] [Related]
55. Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation. Zoble RG; Brewington J; Olukotun AY; Gore R Am J Cardiol; 1987 Aug; 60(6):39D-45D. PubMed ID: 3307366 [TBL] [Abstract][Full Text] [Related]
56. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation. Chiladakis JA; Stathopoulos C; Davlouros P; Manolis AS Int J Cardiol; 2001 Jul; 79(2-3):287-91. PubMed ID: 11461753 [TBL] [Abstract][Full Text] [Related]
57. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Delle Karth G; Geppert A; Neunteufl T; Priglinger U; Haumer M; Gschwandtner M; Siostrzonek P; Heinz G Crit Care Med; 2001 Jun; 29(6):1149-53. PubMed ID: 11395591 [TBL] [Abstract][Full Text] [Related]
58. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. Kerin NZ; Faitel K; Naini M Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696 [TBL] [Abstract][Full Text] [Related]
59. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. Lundström T; Rydén L J Am Coll Cardiol; 1990 Jul; 16(1):86-90. PubMed ID: 2358610 [TBL] [Abstract][Full Text] [Related]
60. [Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach]. Nedostup AV; Blagova OV; Bogdanova EA; Platonova AA Kardiologiia; 2004; 44(1):31-8. PubMed ID: 15029146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]